Home/Investors/Logos Capital

Logos Capital

Biotech Investor · 2 portfolio companies

Portfolio

2

Focus Areas

4

Top Stage

Phase 2

Investment Focus

Obesity Cardiometabolic Disorders Autoimmune Diseases Endocrinology

Portfolio Companies

Company	Stage	Valuation	Focus
Verdiva Bio	Phase 2	—	Obesity, Cardiometabolic Disorders
Yarrow Bioscience	Phase 1	—	Autoimmune Diseases, Endocrinology

Frequent Co-Investors

OrbiMed1 shared Janus Henderson Investors1 shared Forbion1 shared RA Capital Management1 shared Perceptive Advisors1 shared RTW Investments1 shared General Atlantic1 shared venBio Partners1 shared